Collecting information for certain low-grade ovarian or peritoneal tumors
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study collects health information from people whose ovarian or peritoneal cancer started as a low-grade type but later changed to a higher-grade cancer. It may help researchers better understand how these tumors progress and what to expect over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a tumor that started as a low-grade type in the ovary or the lining of the belly (peritoneum)
- Your cancer later progressed and became a higher-grade carcinoma (a more aggressive cancer type)
- Your starting diagnosis was one of these: low malignant potential ovarian tumor
- Your starting diagnosis was one of these: low-grade serous ovarian cancer
- Your starting diagnosis was one of these: primary peritoneal low malignant potential tumor or low-grade serous peritoneal cancer
- Your starting diagnosis was one of these: psammocarcinoma
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “biomarkers,” meaning measurable signals in blood and tumor tissue, in people with advanced ovarian-type cancers. The goal is to understand these markers and how they relate to the cancer, which may help guide future care.
This is a study that collects information and samples from people diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It helps doctors better understand these cancers by building a clinical and biological database, which may improve care planning in the future.
This trial uses a special imaging technique to study high-grade serous ovarian cancer. It aims to better understand the tumor to improve treatment. If you have advanced ovarian cancer and are scheduled for surgery, you may be eligible.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
This study will collect medical information from people with advanced ovarian, peritoneal, or fallopian tube cancer. The goal is to learn more about these cancers and improve future treatments.
Hear when a new Ovarian Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.